BIO-RAD LABORATORIES, INC. Cash And Cash Equivalents At Carrying Value

• BIO-RAD LABORATORIES, INC. showed an increase of +8.5% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
• This data is from BIO-RAD LABORATORIES, INC.'s annual report (Form 10-K), filed with the SEC on February 13, 2026.
• XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q1 2011: $627.91 million | Q2 2011: $670.30 million | Q3 2011: $671.03 million | Q1 2012: $533.81 million | Q2 2012: $456.49 million | Q3 2012: $426.46 million | Q1 2013: $368.63 million | Q2 2013: $367.00 million | Q3 2013: $291.79 million | Q1 2014: $364.51 million | Q2 2014: $384.67 million | Q3 2014: $424.59 million | Q1 2015: $425.73 million | Q2 2015: $450.13 million | Q3 2015: $507.33 million | Q1 2016: $418.65 million | Q2 2016: $418.65 million | Q3 2016: $417.94 million | Q1 2017: $291.66 million | Q2 2017: $321.58 million | Q3 2017: $328.89 million | Q1 2018: $407.27 million | Q2 2018: $403.01 million | Q3 2018: $434.52 million | Q1 2019: $455.89 million | Q2 2019: $580.68 million | Q3 2019: $561.07 million | Q1 2020: $603.55 million | Q2 2020: $607.58 million | Q3 2020: $840.33 million | Q1 2021: $673.47 million | Q2 2021: $732.84 million | Q3 2021: $859.90 million | Q1 2022: $802.32 million | Q2 2022: $596.58 million | Q3 2022: $517.94 million | Q1 2023: $464.14 million | Q2 2023: $390.00 million | Q3 2023: $457.85 million | Q1 2024: $433.30 million | Q2 2024: $406.90 million | Q3 2024: $410.40 million | Q1 2025: $521.40 million | Q2 2025: $369.30 million | Q3 2025: $395.80 million.
• Over the full 16 years of available data (2010 to 2025), BIO-RAD LABORATORIES, INC.'s Cash And Cash Equivalents At Carrying Value has declined by 41.6%.
• Historical annual values: Fiscal year 2025: $529.80 million | Fiscal year 2024: $488.10 million | Fiscal year 2023: $403.80 million | Fiscal year 2022: $434.20 million | Fiscal year 2021: $470.78 million | Fiscal year 2020: $662.21 million | Fiscal year 2019: $660.67 million | Fiscal year 2018: $431.53 million | Fiscal year 2017: $383.82 million | Fiscal year 2016: $456.26 million | Fiscal year 2015: $457.55 million | Fiscal year 2014: $413.25 million | Fiscal year 2013: $331.55 million | Fiscal year 2012: $463.39 million | Fiscal year 2011: $574.23 million | Fiscal year 2010: $906.55 million.
• Data sourced from SEC EDGAR public filings as of August 10, 2026.

Last verified: August 10, 2026